arrow_back Back to App

Improved Access to Addiction and Mental Illness Treatment

This act aims to improve access to modern medications and therapies for individuals struggling with substance use disorders and serious mental illnesses. Citizens can expect broader support in treatment, including access to long-acting injectable medications and training for medical staff.
Key points
Expanded access to FDA-approved long-acting injectable medications for individuals with substance use disorders and serious mental illness.
Support for lab testing and supportive counseling for substance use disorder and serious mental illness.
Training for medical personnel on the use of new treatment methods, combined with clinical services like counseling.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4030
Sponsor: Rep. Dunn, Neal P. [R-FL-2]
Process start date: 2025-06-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Treatment Continuity Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4030.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-06-17.

What are the main provisions?

Key points include:

  • Expanded access to FDA-approved long-acting injectable medications for individuals with substance use disorders and serious mental illness.
  • Support for lab testing and supportive counseling for substance use disorder and serious mental illness.
  • Training for medical personnel on the use of new treatment methods, combined with clinical services like counseling.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Dunn, Neal P. [R-FL-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health